BOH vs DBRG

BOH exhibits a mixed financial profile with a weak Piotroski F-Score of 4/9 indicating marginal financial health, and no available Altman Z-Score limits distress risk assessment. The stock shows strong profitability metrics including a 27.18% profit margin and 39.56% operating margin, alongside robust earnings growth of 29% YoY and solid dividend yield of 3.78%. However, elevated valuation multiples relative to peers, lack of key financial data (debt/equity, cash flow), and bearish insider activity temper optimism. While growth and profitability are strong, structural data gaps and insider selling warrant caution despite positive earnings momentum.

DBRG exhibits a significant disconnect between its market price ($15.60) and its fundamental value, with a Piotroski F-Score of 4/9 indicating only stable health and a Graham Number of $8.81. While the stock has seen strong 1-year price momentum (+86.3%), this is not supported by the underlying financials, which show negative revenue growth (-27.6%) and negative ROE/ROA. The valuation is extreme, evidenced by a Price/Sales ratio of 30.31 and a PEG ratio of 3.06, suggesting the stock is trading at a speculative premium far above its intrinsic value of $3.36.